Monica Jung and Helena Cangadis-Douglass awarded MARC-CMUS PhD Scholarships to address the global priority of opioid misuse

Monash Health pharmacist Monica Jung and Austin Health pharmacist Helena Cangadis-Douglass have been awarded the inaugural Monash Addiction Research Centre (MARC) - Centre for Medicine Use and Safety (CMUS) Scholarships for PhD research into safe and effective opioid use.

Both Monica and Helena completed Monash’s Graduate Entry Pharmacy program. Prior to studying pharmacy, Monica completed a degree in biochemistry at University of Rochester, New York, and worked in adverse drug event monitoring at Seoul St Mary’s Hospital, Korea. Helena completed Biomedical Science (Hons.) program at Monash Health researching lung aeration at birth. Most recently, Helena worked as a Research Officer at CMUS investigating trajectories of benzodiazepine use.


Monica and Helena will analyse linked health data from Victoria and New South Wales through Outcome Health’s Population Level Analysis and Reporting (POLAR) Tool. The PhD program will involve training in health data analytics and advanced epidemiological methods, and collaborating with leading national and international clinical and policy partners.

Centre for Medicine Use and Safety Director Professor Simon Bell said “As outstanding pharmacists, Monica and Helena are well positioned to take advantage of the rapid advances in availability of electronic medical record data to generate new evidence for medication safety.”

Monica and Helena’s PhD research will be supervised by a team that includes Associate Professor Nielsen, Dr Jenni Ilomaki and Professor Bell.